FeRiva 21/7none

Other Combinations

Brand: Avion Pharmaceuticals

Tablet or PillOther CombinationsOn Market
Click to view full label

Net Contents

28 Tablet(s)

Serving Size

1 Tablet(s)

Servings Per Container

28

Supplement Form

Tablet or Pill

Bar Code (UPC/SKU)

3 75854 31828 2

Product Version

Rev. 1219-02

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

6Active Ingredients

6 distinct active ingredients are disclosed in Supplement Facts.

100%Amount Transparency

Every active ingredient discloses a specific amount per serving.

5% Daily Value Coverage

5 ingredients report a %DV; 4 meet or exceed 100% DV.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Supplement Facts

Serving Size: 1 Tablet(s) · 1 per day

IngredientAmount Per Serving% Daily Value
Vitamin C(Ascorbic Acid)175 mg292%
Zinc(Zinc Bisglycinate)10 mg67%
Vitamin B12(Cyanocobalamin)12 mcg200%
Iron(Ferrous Asparto Glycinate)75 mg417%
Folate1200 mcg DFE430%
(6S)-N5-Methyltetrahydrofolic Acid Calcium Salt800 mcg
Folic Acid400 mcg
Succinic Acid150 mg

Not Present

Other Ingredients

Croscarmellose SodiumDicalcium PhosphateMagnesium StearateMicrocrystalline CelluloseSilicon DioxideStearic AcidFD&C Red #40HydroxypropylmethylcelluloseTitanium DioxideTriacetinFD&C Red #3FD&C Blue #1

Target Groups

Adult (18 - 50 Years)Pregnant WomenLactating

Label Claims

NutrientAll OtherStructure/Function

Directions & Suggested Use

Suggested/Recommended/Usage/Directions

Once daily 28-day iron supplement regimen

Suggested/Recommended/Usage/Directions

Dosage and administration: Usual dosage is one tablet daily with or without food or as prescribed by your healthcare provider. The FeRiva 21/7 tablets blister pack supplies a 28-day course of iron therapy that consists of 21 red iron tablets and 7 purple placebo tablets. Take 1 red iron tablet daily for 21 days, followed by 1 purple placebo tablet daily for 7 days. After 28 tablets have been taken a new course may be started if prescribed.

Warnings & Precautions

Precautions re: Children

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions re: All Other

Precautions: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

Precautions re: Pregnant or Nursing or Prescription Medications

While prescribing this nutritional supplement for pregnant women, nursing mothers or for women prior to conception, their medical condition and other drugs, herbs and/or supplements consumption should be considered.

Precautions re: Allergies

Adverse reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Precautions re: Children

Keep out of reach of children.

Storage

Storage

Store between 20 degrees - 25 degrees C (68 degrees - 77 degrees F).

Formulation

Formulation re: Other

Unique, innovative iron supplementation system Enhanced GI tolerability Improved absorption Easy-to-swallow tablets

Formula re: Contains

Description: FeRiva 21/7 tablets for oral administration is a 28-day iron supplement regimen that consists of 21 red, oval-shaped iron tablets and 7 purple, oval-shaped placebo tablets. Each red, oval-shaped iron tablet is debossed with “21” and “7” separated by a line in the middle on the top-side of the tablet and blank on the other side. Each purple, oval shaped placebo tablet is blank on both sides of the tablet.

Formulation re: Other

Indications: FeRiva 21/7 is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency. Contraindictions: FeRiva 21/7 is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.

Formula re: Contains

How supplied: FeRiva 21/7 tablets blister pack (75854-318-28) contains 21 red iron tablets and 7 purple placebo tablets.

FDA Statements

FDA Statement of Identity

Dietary Supplement

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Other Label Statements

General Statements: All Other Content

75854-318-28 RX only

General Statements: All Other Content

The listed product number is not a National Drug Code. Instead Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and health insurance computer systems.

Brand IP Statement(s) re: (c), (TM), (SM)

Sumalate is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814, 8,007,846, and 8,425,956.

General Statements: All Other Content

L-0057

Manufacturer & Distributor

Manufacturer

Avion Pharmaceuticals, LLC

Alpharetta, GA, 30005

1.888.612.8466

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2021-12-18. DSLD Label ID: 264214. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.